22nd century announces executive leadership changes

Expands board with new highly accomplished independent director strengthens balance sheet and implements $15 million cost reduction initiative buffalo, n.y., july 24, 2023 (globe newswire) -- 22nd century group, inc. (nasdaq: xxii), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, announced today that john miller, who leads the tobacco business unit, has been appointed as interim chief executive officer.
XXII Ratings Summary
XXII Quant Ranking